Filing Flows › ANI Pharmaceuticals (ANIP) › Who owns the stock
Who owns ANI Pharmaceuticals (ANIP) stock
287 funds reported ANI Pharmaceuticals (ANIP) shares in their latest 13F filings, worth $1.9B in all. The largest holder is BlackRock ($245M). Last quarter 156 funds added to their stakes and 103 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 2,958,646 | $245M | increase | 2026-06-30 |
| Vanguard Group | 1,305,068 | $103M | increase | 2025-12-31 |
| Soleus Capital Management, L.P. | 867,760 | $71.8M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 838,224 | $69.4M | increase | 2026-06-30 |
| State Street | 831,647 | $68.9M | increase | 2026-06-30 |
| Tang Capital Management LLC | 707,500 | $58.6M | unchanged | 2026-06-30 |
| Dimensional Fund Advisors LP | 623,463 | $51.6M | increase | 2026-06-30 |
| American Century Companies | 574,474 | $47.6M | increase | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 562,016 | $46.5M | decrease | 2026-06-30 |
| Global Alpha Capital Management | 558,003 | $46.2M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 536,407 | $44.4M | increase | 2026-06-30 |
| Millennium Management LLC | 507,207 | $42.0M | decrease | 2026-06-30 |
| Nuveen, LLC | 415,024 | $34.4M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 407,281 | $33.7M | increase | 2026-06-30 |
| Ranger Investment Management, L.P. | 343,150 | $28.4M | decrease | 2026-06-30 |
ANI Pharmaceuticals' latest quarter
ANI Pharmaceuticals, Q3 2026: revenue $291M (+28% year over year), operating margin 18.0%, net earnings $35.1M, operating cash flow $83.8M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ANIP stock?
By the latest 13F filings: BlackRock ($245M); Vanguard Group ($103M); Soleus Capital Management, L.P. ($71.8M); Vanguard Capital Management LLC ($69.4M); State Street ($68.9M).
What is the short interest in ANIP?
3,472,078 shares were sold short at the 2026-10-15 settlement, -0.55% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.